NASDAQ:BIB ProShares Ultra Nasdaq Biotechnology (BIB) Price, Holdings, & News → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free BIB Stock Alerts $49.11 +0.91 (+1.89%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$48.33▼$49.9250-Day Range$48.01▼$62.2652-Week Range$40.10▼$62.45Volume16,046 shsAverage Volume39,562 shsMarket Capitalization$80.05 millionAssets Under Management$77.94 millionDividend Yield0.14%Net Expense Ratio0.95% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get ProShares Ultra Nasdaq Biotechnology alerts: Email Address About ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Read More BIB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIB ETF News HeadlinesMarch 25, 2024 | investorplace.comWall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy RichMarch 22, 2024 | msn.comProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0403April 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. February 22, 2024 | investorplace.com3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024December 20, 2023 | msn.comProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0383December 15, 2023 | insidermonkey.com5 Most Promising Biotech Stocks to Buy According to AnalystsOctober 29, 2023 | investing.comBIB ETF Stock Price HistoryJune 18, 2023 | fool.comProShares Trust - ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB)April 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. May 30, 2023 | finance.yahoo.comBIB - ProShares Ultra Nasdaq BiotechnologySee More Headlines Receive BIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerProShares Fund NameProShares Ultra Nasdaq Biotechnology Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BIB Inception Date4/6/2010 Fund ManagerMichael Neches, Tarak Dave Webwww.proshares.com Phone+1-240-4976400Fund Focus Asset ClassEquity BenchmarkNasdaq Biotech Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings331 Fund Statistics Assets Under Management$77.94 million Average Daily Volume$44,101.60 Discount/Premium0.05% Leveraged2.00 Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume38 Put Options29 Call Options9 Short Interest12,300 shs Miscellaneous Outstanding Shares1,630,000Beta1.63 Creation Unit50,000 Creation Fee$250.00 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry ProShares Ultra Nasdaq Biotechnology ExpensesTypeBIBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.75%0.56%0.54%0.48%0.51%Other Expenses0.33%0.40%0.54%0.34%0.58%Total Expense1.08%0.72%0.70%0.58%0.70%Fee Waiver-0.13%-0.53%-0.55%-0.22%-0.57%Net Expense0.95%0.60%0.60%0.54%0.58% ProShares Ultra Nasdaq Biotechnology (BIB) Holdings & ExposureTop 10 BIB HoldingsNASDAQ BIO INDEX SWAP BNPHolding Weight: 42.28%NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGHolding Weight: 37.42%NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAHolding Weight: 17.35%NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEHolding Weight: 12.62%NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONALHolding Weight: 6.88%Amgen(NASDAQ:AMGN)Holding Weight: 6.33%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 6.17%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 6.11%Gilead Sciences(NASDAQ:GILD)Holding Weight: 6.06%NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAHolding Weight: 5.42%BIB Sector ExposureBIB Industry ExposureFull Holdings Details Similar ETFsPrincipal Healthcare Innovators ETFNASDAQ:BTECInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHHorizon Kinetics Medical ETFNASDAQ:MEDXInstitutional OwnershipToth Financial Advisory CorpBought 14,870 shares on 4/16/2024Ownership: 1.632%Clarity Capital Partners LLCBought 3,530 shares on 2/20/2024Ownership: 0.221%Cassaday & Co Wealth Management LLCSold 29,415 shares on 2/14/2024Ownership: 0.281%Tower Research Capital LLC TRCSold 5,015 shares on 2/13/2024Ownership: 0.090%Cassaday & Co Wealth Management LLCSold 29,415 shares on 2/9/2024Ownership: 0.281%View All Institutional Transactions BIB ETF - Frequently Asked Questions How have BIB shares performed in 2024? ProShares Ultra Nasdaq Biotechnology's stock was trading at $57.05 at the start of the year. Since then, BIB shares have decreased by 13.9% and is now trading at $49.11. View the best growth stocks for 2024 here. Are investors shorting ProShares Ultra Nasdaq Biotechnology? ProShares Ultra Nasdaq Biotechnology saw a decline in short interest in March. As of March 31st, there was short interest totaling 12,300 shares, a decline of 77.9% from the March 15th total of 55,700 shares. Based on an average daily volume of 41,500 shares, the days-to-cover ratio is currently 0.3 days. View ProShares Ultra Nasdaq Biotechnology's Short Interest. How often does ProShares Ultra Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares Ultra Nasdaq Biotechnology? ProShares Ultra Nasdaq Biotechnology declared a dividend on Tuesday, March 19th. Stockholders of record on Thursday, March 21st will be paid a dividend of $0.0403 per share on Wednesday, March 27th. The ex-dividend date of this dividend is Wednesday, March 20th. Read our dividend analysis for BIB. What does BIB invest in? ProShares Ultra Nasdaq Biotechnology is a equity fund issued by ProShares. BIB focuses on health care investments and follows the Nasdaq Biotech Index. The fund's investments total to approximately $77.94 million assets under management. What stocks does ProShares Ultra Nasdaq Biotechnology hold? BIB invests in 331 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), AstraZeneca (AZN), Moderna (MRNA), Biogen (BIIB), Illumina (ILMN), Alnylam Pharmaceuticals (ALNY) and BioMarin Pharmaceutical (BMRN). What is the management fee for ProShares Ultra Nasdaq Biotechnology? ProShares Ultra Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 0.33%. However, BIB has a fee waiver of -0.13% to reimburse the expenses. The net expense ratio for BIB is 0.95%. What other stocks do shareholders of ProShares Ultra Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Nasdaq Biotechnology investors own include Walt Disney (DIS), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), Starbucks (SBUX), Advanced Micro Devices (amd), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Visa (V). Who are ProShares Ultra Nasdaq Biotechnology's major shareholders? ProShares Ultra Nasdaq Biotechnology's stock is owned by a variety of retail and institutional investors. Top institutional investors include Toth Financial Advisory Corp (1.63%). How do I buy shares of ProShares Ultra Nasdaq Biotechnology? Shares of BIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BIB) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
